Hikma Introduces A Pair Of US Injectables

Builds On Strong Slate Of Launches Over Past Year

 
• By Dave Wallace

Hikma has added to its injectables portfolio in the US with the launches of dexmedetomidine and docetaxel.

US Rockets Fireworks Launch
Hikma has launched Dexmedetomidine and Docetaxel In the US • Source: Alamy

More from Products

More from Generics Bulletin